AUG 10, 2026 · JOURNAL ARTICLE
Zero‐Valent Ruthenium‐Anchored Nanozymes Remodel Tumor Microenvironment for Malignant Tumor Treatment in Combination With αPD‐L1 Immunotherapy
Exploration
In vitro and computational mechanistic work on a novel nanomaterial demonstrates catalytic activity and theoretical potential, but lacks in vivo efficacy data, clinical endpoints, or controlled comparisons to support therapeutic claims.
Study details
InterventionZero-valent ruthenium-anchored iron-based (…